Medicine
Oncology

Prostate cancer
Prognosis


Home > Disciplines > Medicine > Oncology > Prostate cancer > Prognosis


CONTENTS



OVERVIEW
OVERVIEW ON PREDICTION TOOLS
NATURAL HISTORY
NOMOGRAMS
PARTIN TABLES
RISK CLASSIFICATION
ONLINE PREDICTION TOOLS






TOOLS FOR PREDICTION OF LIFE EXPECTANCY (BEFORE TREATMENT)
PREDICTIONS ON LIFE EXPECTANCY






TOOLS FOR PREDICTION OF PATHOLOGICAL STAGE (BEFORE TREATMENT)
PREDICTION ON BIOPSY OUTCOME
PREDICTIONS AT INITIAL DIAGNOSIS
PREDICTION OF GRADE/STAGE BEFORE RADICAL PROSTATECTOMY
PREDICTION OF GLEASON SCORE UPGRADING
PREDICTION OF POSITIVE LIMPH NODES AND/OR EXTRAPROSTATIC EXTENSION






TOOLS FOR PREDICTION OF SURVIVAL AND CANCER-SPECIFIC MORTALITY (BEFORE/AFTER TREATMENT)
DISEASE SPECIFIC MORTALITY
COMPETING MORTALITY
After treatment
PREDICTIONS AT BCR AFTER RADICAL PROSTATECTOMY
PREDICTION OF SURVIVAL FOLLOWING BCR AFTER RP
PREDICTION OF SURVIVAL AFTER SALVAGE TREATMENT






TOOLS FOR PREDICTION OF BIOCHEMICAL RECURRENCE (BEFORE/AFTER TREATMENT)
PREDICTIONS ON MONITORING OUTCOMES
PREDICTION OF BCR USING GLEASON GRADE GROUPS
PREDICTIONS ON OUTCOMES OF USE OF COMMON MEDICATIONS
PREDICTIONS ON OUTCOMES OF USE OF STATINS
Before treatment
PREDICTION OF BCR AFTER RP USING PRE-TREATMENT DATA
After treatment
PREDICTIONS ON OUTCOMES AFTER PRIMARY TREATMENT
PREDICTIONS ON (PRIMARY) RADICAL PROSTATECTOMY OUTCOMES
PREDICTIONS ON OUTCOMES OF PRIMARY RADIOTHERAPY
PREDICTION OF BCR AFTER RP USING POST-TREATMENT DATA
PREDICTION OF TIME TO BCR AFTER RADICAL PROSTATECTOMY
PREDICTIONS ON OUTCOMES OF NEOADJUVANT ADT
PREDICTIONS ON OUTCOMES AFTER SALVAGE TREATMENT
PREDICTIONS ON OUTCOMES OF RADIOTHERAPY FOLLOWING PRIMARY RP
PREDICTIONS ON OUTCOMES OF PELVIC IRRADIATION
PREDICTIONS ON OUTCOMES OF RP FOLLOWING PRIMARY RADIOTHERAPY
Clinical recurrence
PREDICTION OF CLINICAL RECURRENCE AFTER RADICAL PROSTATECTOMY






TOOLS FOR PREDICTION OF METASTATIC PROGRESSION (AFTER TREATMENT)
PREDICTION OF METASTASIS AFTER PRIMARY TREATMENT
PREDICTION OF CASTRATION RESISTANCE






BIOMARKERS AND GENOMICS
AGE AT DIAGNOSIS
CIRCULATING TUMOR CELLS
GLEASON SCORE
MAGNETIC RESONANCE IMAGING
METABOLIC FACTORS
POSITIVE BIOPSY CORES
POSITIVE SURGICAL MARGINS
PROSTATE CANCER ANTIGEN 3 (PCA3)
PROSTATE CANCER RISK INDEX (PRIX)
PSA AFTER RP
PSA AFTER RT FOLLOWING RP
PSA BEFORE RP
PSA DENSITY
PSA KINETICS
SURGEON EXPERIENCE
TESTOSTERONE LEVEL
TUMOR CONTACT LENGHT
TUMOR VOLUME






PREDICTION OF OUTCOMES BY CLASS OF PATIENTS
OLDER PATIENTS
PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER
PATIENTS WITH DIABETES
PATIENTS WITH FAMILY HISTORY
PATIENTS WITH HIGH-RISK PROSTATE CANCER
PATIENTS WITH LOCALIZED PROSTATE CANCER
PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER
PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER
PATIENTS WITH ELEVATED PSA AS SOLE PREOPERATIVE RISK FEATURE
YOUNGER PATIENTS